| HOME >> BIOLOGY >> TECHNOLOGY |
Leading Scalp and Hair Care Company Enters Agreement with HairDX to Offer
Consumer-Friendly Hair Loss Test
ATLANTA, March 6 /PRNewswire/ -- NIOXIN(R) Research Laboratories Inc., the leader in professional skincare for the scalp, today announced that it will offer an easy to access and understand genetic test that determines the likelihood of developing male pattern baldness -- before it actually begins to happen. Similarly, a test for women is being developed and may be available soon.
NIOXIN(R) has entered into an agreement with HairDX, a biotech start-up based in Irvine, CA, to offer the test as part of its next generation effort in introducing scientifically proven scalp and hair products. HairDX is the first genome test to be made available to consumers in helping assess their risk and genetic predisposition for developing pattern baldness (Androgenetic Alopecia). This new genetic test is accessible through the internet at http://www.nioxin.com and will be promoted at consumer education events held nationally beginning March 1st 2008.
According to the American Hair Loss Association, by the age of 35, two-thirds of American men will experience some degree of appreciable hair loss and by the age of 50, approximately 85% of men will have significantly thinning hair.
"Gaining a better understanding of the potential cause of an individual's condition enables a more accurate assessment of the most appropriate solution," said Eva Graham, founder of NIOXIN(R) Research Laboratories, Inc.
"HairDX is proud to work with NIOXIN(R) to help genetic science make a positive contribution to scalp and hair care," said Andy Goren, CEO of HairDX. "This provides a personalized profile for many individuals who can benefit from knowing their risk of hair loss and allow them to take action early, before the condition becomes severe."
HOW IT WORKS:
The participan
'/>"/>
| SOURCE NIOXIN Research Laboratories Inc. Copyright©2008 PR Newswire. All rights reserved |